Tiny Gem

Freight Technologies Inc.’s (NASDAQ: FRGT) CFO, Paul Freudenthaler, and President Mike Flinker, Present Company’s Latest Corporate Updates at the H.C. Wainwright 24th Annual Global Investment Conference

  • Fr8Tech’s August 15, 2022, corporate update formed the backbone for its presentation at the H.C. Wainwright 24th Annual Global Investment Conference held from September 12-14, 2022
  • The company was represented by Paul Freudenthaler and Mike Flinker, who also talked about the company’s role in revolutionizing cross-border shipping, and the role of AI and machine learning in solving current logistical problems in the industry within the NAFTA region
  • Fr8Tech remains committed to exploring new ways to create more value for its clients and streamline the region’s cross-border shipping process, and leveraging technology
  • Javier Selgas, the company’s CEO, maintains that Fr8Tech anticipates steady long-term growth, especially as the market conditions improve and fuel prices stabilize

Since its founding in 2015, Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) has been known for developing advanced technological solutions, including AI and machine learning, to optimize and automate the supply chain process, offering a platform for cross-border shipping in the NAFTA region for business-to-business (“B2B”) clients.  Beginning in 2019, it refocused its B2B offerings away from freight forwarders and towards business clients directly, without an intermediary and supported by the Company’s staff.

On August 15, 2022, Freight Technologies provided its latest corporate update. Of note was the filing of a Form F-1 with the United States Securities and Exchange Commission (“SEC”) in a move which Javier Selgas, the company’s Chief Executive Officer (“CEO”), sees positioning Fr8Tech for continued growth as a public company (https://ibn.fm/Xk6bE).

The last corporate update formed the backbone for Fr8Tech’s presentation at the H.C. Wainwright 24th Annual Global Investment Conference held from September 12-14, 2022, at the Lotte New York Palace Hotel (https://ibn.fm/ESvoD).

Representing the company was Paul Freudenthaler, the Chief Financial Officer (“CFO”), and Mike Flinker, the President. In addition to the company’s F-1 filing with the SEC, the two talked in-depth about the company’s role in revolutionizing cross-border shipping and the investments made towards the end of 2021 and into 2022 to establish a domestic offering for each of the US and Mexico, to complement the Company’s core cross-border offerings.  They also noted the increasingly important role of Artificial Intelligence (“AI”) and machine learning in solving the current problems that players in the logistics industry within the NAFTA region are grappling with.  “AI will continue to affect our service offerings which in turn will only improve more as the traffic on our platform increases over time.”

This year’s theme for the Global Investment Conference was life sciences, cryptocurrency, blockchain and fintech, metals and mining, technology, media, and telecommunications growth, as well as cleantech. Fr8Tech presented alongside other key companies within these spaces, with its focus on technology, while also touching on its investment rationale which includes the company’s target market of over $1.2 trillion in freight, its scalable and differentiated technology, its market leadership as a first mover in this space in Mexico, and its successful growth strategy to date.

Just this year, the company has grown its operations with numerous improvements to its cloud-based marketplace that simplifies the once-complex process of international over-the-road (“OTR”) cross-border shipping (https://ibn.fm/sEMFx). Fr8Tech is also constantly exploring new ways to create value for its clients and streamline the region’s cross-border shipping process and carry that over into their respective domestic markets.  “We have had some top consumer companies endorse our product by starting with a purely domestic product and then, after familiarizing themselves with our technologies and capabilities, gaining confidence in our reliability and jump into the cross-border offerings on our platform and then perhaps into another country’s domestic requirements.  Our efforts to date have yielded six distinctive solutions in our product suite: Fr8App, Fr8Radar, Fr8TMS, Fr8FMS, Fr8Data, and Fr8Fleet.  Some of these address specific needs, like 24/7 tracking and tracing through Fr8Radar, while others address needs for purely domestic carriage, such as Fr8Fleet.”

The company’s focus on exploring new areas for revenue and value creation allowed for a 45% year-over-year (YOY”) revenue growth for the second quarter of the 2022 financial year (“Q2 2022”) (https://ibn.fm/VSVjD).

“The growth reflects greater traction in each of our dedicated capacity products, Fr8Fleet, and our U.S. domestic Fr8App services,” noted Mr. Selgas.

Mr. Selgas has noted that the company anticipates steady long-term growth, especially as the market conditions improve and fuel prices stabilize. Technology will continue to play an integral role in this growth, even as the company focuses on its logistical operations’ transparency and overall efficiency.

For more information, visit the company’s website at www.Fr8Technologies.com

NOTE TO INVESTORS: The latest news and updates relating to FRGT are available in the company’s newsroom at https://ibn.fm/FRGT

Corporate Communications
IBN (InvestorBrandNetwork)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com

About TinyGems

TinyGems is your guide to the best and brightest in the under-appreciated small-cap sector. As one of 50+ brands within the InvestorBrandNetwork (“IBN”), TinyGems provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution via IBN to reach millions of social media followers; and (5) a full array of corporate communications solutions. It’s time to uncover some of the best-kept secrets on Wall Street. TinyGems features innovative small-cap companies with huge potential, putting a spotlight on the best and brightest of these disruptors that have the technology, the talent, the drive, and the business models to make a huge impact in the markets and in portfolios. Whether it’s a game changing technology, a new more profitable product or service, or a star in a hot sector, TinyGems is the go-to source for actionable intelligence.

To receive SMS text alerts from TinyGems, text “Gems” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TinyGems.com

Please see full terms of use and disclaimers on the TinyGems website applicable to all content provided by TinyGems, wherever published or re-published: https://www.TinyGems.com/Disclaimer

TinyGems Los Angeles, California www.TinyGems.com 310.299.1717 Office Editor@TinyGems.com

TinyGems is part of the InvestorBrandNetwork

Christian Amiscua

Share
Published by
Christian Amiscua

Recent Posts

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Advances PP2A Inhibition Strategy in Evolving Oncology Landscape

Recent research shows how chemotherapy and immunotherapy can complement each other when used together. Within…

2 days ago

Scientists Discover Why Colon Cancer Diagnoses are Increasing in Young Adults

Researchers have found that people under 50 who develop colorectal cancer have unusually rigid colon tissue that helps tumors…

4 days ago

US Military Admits it is Using AI in Attacks Against Iran

The U.S. military has confirmed that AI systems are actively involved in its ongoing operations against Iran, an admission that…

6 days ago

Investing in Innovation: Evaluating the Clinical and Commercial Potential of LB-100 and Liora’s Proton Therapy

LIXTE Biotechnology Holdings and Liora Technologies recently joined forces to soon offer a real fight…

6 days ago

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Expands LB 100 Development Through Strategic Academic and Pharma Partnerships

LIXTE recently expanded its ovarian clear cell cancer trial in partnership with MD Anderson and…

1 week ago

Researchers Trace Differing Pediatric Brain Tumors to Common Source

New research has uncovered a shared biological weakness running across three distinct pediatric brain cancers, a finding…

2 weeks ago